Loop diuretics for patients receiving blood transfusions

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 12, 2015, Pages

  Sarai, Michael ^a   Tejani, Aaron M ^b  

^a KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; ETACRYNIC ACID; FUROSEMIDE; LOOP DIURETIC AGENT; OXYGEN; PLACEBO; TORASEMIDE;

BLOOD TRANSFUSION; CLINICAL PRACTICE; EFFECT SIZE; HUMAN; HYPERVOLEMIA; INSPIRATORY CAPACITY; LUNG EDEMA; META ANALYSIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FUNCTION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADULT; ADVERSE EFFECTS; BODY WATER; CONFIDENCE INTERVAL; NEWBORN; PREMATURITY; PULMONARY EDEMA;

ADULT; BLOOD TRANSFUSION; BODY WATER; CONFIDENCE INTERVALS; FUROSEMIDE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PULMONARY EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84934342596     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010138.pub2     Document Type: Review

References (34)

1. Balegar V KK, Kluckow M. Furosemide for packed red cell transfusion in preterm infants: a randomized controlled trial. Journal of Pediatrics 2011;159(96):913-8. [MEDLINE: 21784442]
2. Nand N, Gupta SP, Gupta MS. Hemodynamic evaluation of blood transfusion in chronic severe anemia with special reference to speed of transfusion. Japanese Heart Journal 1985;26(5):759-65. [MEDLINE: 4087369]
3. Nand N, Gupta MS, Sharma M. Furosemide supplemented blood transfusion in cases of chronic severe anemia. Japanese Heart Journal 1986;27(2):177-82. [MEDLINE: 3723795]
4. Sarkar S, Dechert RE, Becker M, Attar MA, Schumacher RE, Donn SM. Double blind randomized placebo-controlled trial of furosemide therapy after packed red blood cell transfusion in preterm infants [abstract no: 5899.5]. Pediatric Academic Societies' Annual Meeting; 2007 May 5-8; Toronto, Canada. 2007.
5. Sarkar S, Dechert RE, Becker M, Attar MA, Schumacher RE, Donn SM. Double-masked, randomized, placebo-controlled trial of furosemide after packed red blood cell transfusion in preterm infants. Journal of Neonatal-Perinatal Medicine 2008;1(1):13-9.
6. Harrison KA, Ajabor LN, Lawson JB. Ethacrynic acid and packed-blood-cell transfusion in treatment of severe anaemia in pregnancy. Lancet 1971;1(7688):11-4. [MEDLINE: 4099313]
7. Reiter PD, Makhlouf R, Stiles AD. Comparison of 6-hour infusion versus bolus furosemide in premature infants. Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy 1998;18(1):63-8. [MEDLINE: 9469683]
8. McNamara P. A randomized controlled trial of furosemide to prevent fluid overload during red blood cell transfusion in neonates. clinicaltrials.gov/ct2/show/NCT00618852 (accessed 9 February 2015).
9. Agrawal AK, Hsu E, Quirolo K, Neumayr LD, Flori HR. Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary?. Pediatric Blood & Cancer 2012; Vol. 58, issue 3:466-8. [MEDLINE: 21793178]
10. Alam A, Lin Y, Lima A, Hansen M, Callum JL. The prevention of transfusion-associated circulatory overload. Transfusion Medicine Reviews 2013; Vol. 27, issue 2:105-12. [MEDLINE: 23465703]
11. Bolton-Maggs PH, Poles D, Watt A, Thomas D, Cohen H on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2012 Annual SHOT Report (2013). www.shotuk.org/wp-content/uploads/2013/08/SHOT-Annual-Report-2012.pdf (accessed 9 February 2015).
12. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). British Journal of Haematology 2007;136(6):788-99. [MEDLINE: 17341264]
13. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). Journal of the American College of Cardiology 2001;38(7):2114-30. [MEDLINE: 11738323]
14. Eades SK, Christensen ML. The clinical pharmacology of loop diuretics in the pediatric patient. Pediatric Nephrology 1998;12(7):603-16. [MEDLINE: 9761364]
15. Fry J, Arnold D, Clase C, Crowther M, Holbrook AM, Traore AN, et al. Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion 2010;50(8):1722-30. [MEDLINE: 20345566]
16. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesthesia & Analgesia 2009;108(3):759-69. [MEDLINE: 19224780]
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
18. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
19. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements 2012; Vol. 2, issue 1:1-138. [DOI: 10.1038/kisup.2012.1]
20. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44(12):1774-89. [MEDLINE: 15584994]
21. Li G, Rachmale S, Kojicic M, Shahjehan K, Malinchoc M, Kor DJ, et al. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients. Transfusion 2011; Vol. 51, issue 2:338-43. [MEDLINE: 20723173]
22. Lieberman L, Maskens C, Cserti-Gazdewich C, Hansen M, Lin Y, Pendergrast J, et al. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfusion Medicine Reviews 2013; Vol. 27, issue 4:206-12. [MEDLINE: 24075097]
23. Murphy EL, Kwaan N, Looney MR, Gajic O, Hubmayr RD, Gropper MA, et al. Risk factors and outcomes in transfusion-associated circulatory overload. American Journal of Medicine 2013; Vol. 126, issue 4:357.e29-38. [MEDLINE: 23357450]
24. O'Donovan BH, Bell EF. Effects of furosemide on body water compartments in infants with bronchopulmonary dysplasia. Pediatric Research 1989;26(2):121-4. [MEDLINE: 2771518]
25. Public Health Agency of Canada. Transfusion Transmitted Injuries Surveillance System - Program Report 2004-2005. www.phac-aspc.gc.ca/hcai-iamss/tti-it 2008.
26. Piccin A, Cronin M, Murphy C, Eakins E, Lawlor E. Transfusion associated circulatory overload incidence and risk factors. 51st Annual Meeting. American Society of Hematology (ASH); 2009 Dec 5-8; New Orleans, USA. 2009.
27. Popovsky MA. Transfusion and the lung: circulatory overload and acute lung injury. Vox Sanguinis 2004;87 Suppl 2:62-5. [MEDLINE: 15209881]
28. Popovsky MA, Robillard P, Schipperus M, Stainsby D, Tissot JD, Wiersum J. ISBT Working Party on Haemovigilance. Proposed standard definitions for surveillance of noninfectious adverse transfusion reactions. www.ihn-org.com/wp-content/uploads/2011/06/ISBT-definitions-for-non-infectious-transfusion-reactions.pdf (accessed 9 February 2015).
29. Schuster CJ, Weil MH, Besso J, Carpio M, Henning RJ. Blood volume following diuresis induced by furosemide. American Journal of Medicine 1984;76(4):585-92. [MEDLINE: 6711572]
30. Skeate RC, Eastlund T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Current Opinion in Hematology 2007;14(6):682-7. [MEDLINE: 17898575]
31. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, et al. Transfusion-related acute lung injury: definition and review. Critical Care Medicine 2005;33(4):721-6. [MEDLINE: 15818095]
32. US Food, Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2012. www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm (accessed 9 February 2015).
33. Zhou L, Giacherio D, Cooling L, Davenport RD. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005; Vol. 45, issue 7:1056-63. [MEDLINE: 15987348]
34. Sarai M, Tejani AM. Loop diuretics for patients receiving blood transfusions. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD010138]